TLDR Minoxidil not effective in preventing chemotherapy-induced hair loss.
The study evaluated the effectiveness of Minoxidil (Mx) 2% topical solution in preventing doxorubicin-induced alopecia in 48 female cancer patients. The patients were randomly assigned to receive either Mx or a placebo, and both groups showed severe alopecia with no significant difference between them. The study concluded that Mx 2% topical solution was non-toxic but not effective in preventing chemotherapy-induced alopecia. The study suggests that few trials have been conducted to prevent chemotherapy-induced alopecia, and Mx, which is used to induce hair growth in men with male-pattern baldness, was not effective in preventing doxorubicin-induced alopecia.
Cited in this study
1 / 1 results
15 citations
,
July 1993 in “The journal of investigative dermatology/Journal of investigative dermatology” Retinoids can change the hair growth cycle by extending the growth phase and shortening the rest phase.
1 citations
,
November 2022 in “JAAD case reports” Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.
1 citations
,
August 2021 in “Cosmoderma”
117 citations
,
August 2019 in “Drug Design Development and Therapy” Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.
36 citations
,
November 2016 in “Australasian Journal of Dermatology” Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.
48 citations
,
August 2010 in “PubMed” Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.
49 citations
,
October 1994 in “Annals of Oncology” Minoxidil not effective in preventing chemotherapy-induced hair loss.
82 citations
,
March 1994 in “Archives of Dermatology” 2% topical minoxidil effectively treats female hair loss with minimal side effects.
58 citations
,
October 1993 in “International Journal of Dermatology” Minoxidil helps hair growth and reduces shedding in women.